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1508 wiAbstract
Bacterial outer membrane vesicles (OMVs) are nano‐sized compartments consisting of a lipid
bilayer that encapsulates periplasm‐derived, luminal content. OMVs, which pinch off of Gram‐
negative bacteria, are now recognized as a generalized secretion pathway which provides a
means to transfer cargo to other bacterial cells as well as eukaryotic cells. Compared with other
secretion systems, OMVs can transfer a chemically extremely diverse range of cargo, including
small molecules, nucleic acids, proteins, and lipids to proximal cells. Although it is well recognized
that OMVs can enter and release cargo inside host cells during infection, the mechanisms of host
association and uptake are not well understood. This review highlights existing studies focusing
on OMV‐host cell interactions and entry mechanisms, and how these entry routes affect cargo
processing within the host. It further compares the wide range of methods currently used to dis-
sect uptake mechanisms, and discusses potential sources of discrepancy regarding the mecha-
nism of OMV uptake across different studies.1 | INTRODUCTION
Outermembrane vesicles (OMVs) are nano‐sized proteoliposomes shed
from the cell envelope of all Gram negative species of bacteria studied
to date (Amano, Takeuchi, & Furuta, 2010). Originally considered an
artefact of cell wall turnover or lysis, their release from the bacterial cell
is now recognized as a generalized secretion system that contributes to
enhanced fitness, and facilitates interactions between cells in the con-
text of mixed bacterial communities and during host–microbe interac-
tions (Bonnington&Kuehn, 2014; Haurat, Elhenawy, & Feldman, 2015).
OMVs are typically 20–200 nm in diameter, and are released dur-
ing all growth phases and in all environmental conditions studied to
date (Bonnington & Kuehn, 2014). OMVs are capable of delivering a
chemically diverse range of cargo over long distances while protecting
vesicular contents from the external environment (Bonnington &
Kuehn, 2014). Cargo can either be contained as a solute within the
vesicle lumen, or can be incorporated into or associated with the mem-
brane bilayer, and can include nucleic acids such as siRNA and DNA,
toxins, and cell wall components such as peptidoglycan and lipopoly-
saccharide (LPS; Renelli, Matias, Lo, & Beveridge, 2004; Lindmark
et al., 2009; Kaparakis et al., 2010; Vanaja et al., 2016; Koeppen
et al., 2016). Due to their versatility as a delivery vehicle, the contribu-
tions of OMVs to bacterial fitness are equally varied, but of increasingCreative Commons Attribution Li
ed by John Wiley & Sons Ltd
leyonlinelibrary.com/journal/cmiinterest is their role in host colonization and disease pathogenesis
(Kuehn & Kesty, 2005). Secretion of OMVs is generally considered
an adaptive response to stress, and infection often occurs within a
stressful environment (MacDonald & Kuehn, 2012). In some cases,
increased production of OMVs under stressful conditions is correlated
with increased survival, such as in the presence of antimicrobial pep-
tides, and vesiculation increased resistance to bacteriophage infection
(Manning & Kuehn, 2011). Pathogenic species of bacteria generally
release more OMVs than their non‐pathogenic counterparts, and it is
likely that OMV secretion has been adapted by pathogens to enhance
their virulence (Horstman & Kuehn, 2000). Pseudomonas aeruginosa
OMVs isolated from a cystic fibrosis patient showed a 3–4 fold higher
association with lung cells than OMVs from a lab adapted strain, PAO1,
via the interaction between vesicle‐associated Pseudomonas amino-
peptidase (PaAp) and the lung cells, suggesting an important role for
OMV cargo in an infection setting (Bauman & Kuehn, 2009).
OMVs have defensive roles during infection, by sequestering anti-
biotics and antibodies, as well as acting as decoy antigens to divert the
attention of the immune system away from the bacterial cell
(Chattopadhyay & Jaganandham, 2015; Ellis & Kuehn, 2010;
Vidakovics et al., 2010). The potency of OMVs as offensive weapons
is demonstrated by their ability to induce fatal sepsis even in the
absence of intact bacterial cells (Park et al., 2010).cense, which permits use, distribution and reproduction in any medium, provided
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O'DONOGHUE AND KRACHLER 1509OMVs are also able to deliver a selection of virulence factors,
including toxins, adhesins, and immunomodulatory molecules directly
into host cells during infection (Alaniz, Deatherage, Lara, & Cookson,
2007; Lindmark et al., 2009; Roy, Hamilton, Munson, & Fleckenstein,
2011). While many of these virulence factors have now been verified
as OMV cargo, with some even preferentially secreted via this path-
way, such as the cytolysin ClyA in enterohemorrhagic E. coli (EHEC),
heat labile enterotoxin (LT) in enterotoxigenic E. coli (ETEC), and the
vacuolating toxin VacA in Helicobacter pylori, identifying the processes
which enable the delivery of OMV associated cargo into host cells has
proved challenging (Horstman & Kuehn, 2000; Wai et al., 2003; Ricci
et al., 2005). This review aims to identify common and contrasting
mechanisms which enable OMV entry and cargo delivery to host cells
during infection.
Endocytosis is a process by which small molecules can cross the
membrane bilayer of a cell (Doherty & McMahon, 2009). In non‐
phagocytic cells, there are four main pathways for the entry of small
solutes: Macropinocytosis, clathrin mediated endocytosis, caveolin
mediated endocytosis, or non‐caveolin, non clathrin mediated endo-
cytosis (Rewatkar, Parton, Parekh, & Parat, 2015). These pathways
have all been implicated in mediating OMV entry into host cells
(Figure 1).FIGURE 1 Routes of OMV entry into host cells. Several different pathways
enter host cells have been described. These routes can require clathrin coat
fusion. OMV entry can be impaired by the use of inhibitors against compo
formation; papain–proteolytically degrades surface protein receptors; mon
inhibits receptor internalization; dynasore–inhibits dynamin GTPase activit
and nystatin–intercalate and disrupt cholesterol‐rich membrane domains; w
N‐WASP, which regulates actin polymerization; cytocholasin D–depolymer2 | MACROPINOCYTOSIS
Macropinocytosis is characterized by the formation of large (over
200 nm in diameter), actin‐driven, ruffled protrusions from the cell
membrane, which allow the sampling and internalization of extracellu-
lar medium (Weiner et al., 2016). Its role in infection has been
observed for Shigella flexneri, which invades host cells via
macropinosomes (Weiner et al., 2016). The pathway is also utilized
by viruses, which are comparable in size to OMVs (Mercer & Helenius,
2008). It has therefore been suggested that OMVs can enter host cells
via macropinocytosis (Kaparakis‐Liaskos & Ferrero, 2015). Inhibition of
actin polymerization by cytochalasin D or wiskostatin has been
observed to reduce the entry of OMVs from P. aeruginosa into airway
epithelial cells (Bomberger et al., 2009). However, macropinocytosis is
generally not a cargo induced process, and it is likely that entry via this
route is not a deliberate OMV‐driven event (Lim & Gleeson, 2011).
Treatment with actin inhibitors is not entirely specific for
macropinocytosis; movement of endosomes also requires actin remod-
eling, and so reduced cargo delivery after these treatments may also be
due to the inadvertent effect on other endocytic routes (Soldati &
Schliwa, 2006). Macropinocytosis allows internalization of endocytic
vesicles up to 1 um in diameter, whereas clathrin dependent andallowing OMVs from a variety of Gram negative species of bacteria to
ed pits, formation of caveolae, and use of lipid rafts or direct membrane
nents of these pathways: chlorpromazine–inhibits clathrin coated pit
ensin–ionophore, dissipates proton gradient; monodansylcadaverine–
y; methyl‐β cyclodextrin–extracts cholesterol from membrane; filipin
ortmannin–inhibits phosphatidylinositol kinases; wiskostatin–inhibits
ises actin
1510 O'DONOGHUE AND KRACHLERcaveolin or lipid raft mediated endocytosis generally allows internaliza-
tion of considerably smaller cargo (120 nm, 60 nm, and 90 nm respec-
tively; Amano et al., 2010). The size of OMVs ranges from 20 to
500 nm, and this diversity may influence their preferred route of
uptake (Amano et al., 2010; Kaparakis‐Liaskos & Ferrero, 2015).3 | CLATHRIN DEPENDENT ENDOCYTOSIS
Clathrin mediated endocytosis occurs via the formation of clathrin
coated pits up to 200 nm in diameter (Vercauteren et al., 2010). Unlike
macropinocytosis, internalization can be triggered by ligand binding to
cell surface receptors (Rewatkar et al., 2015). Budding off of the vesicle
requires dynamin, and the internalized vesicle enters the endosomal
trafficking routes, from where its cargo can be returned to the cell sur-
face or targeted to lysosomes for degradation (Ritter et al., 1995).
Many bacterial virulence factors, such as shiga toxin, cholera toxin,
and the arg‐gingipain adhesin of Porphyromonas gingivalis have been
shown to utilize clathrin mediated endocytosis to gain entry into host
cells during infection (Boisvert & Duncan, 2008.
Sandvig & van Deurs, 2002). Because OMVs are known to trans-
port various virulence factors during infection, it is reasonable to infer
that they can utilize toxin‐receptor interactions to facilitate their cargo
delivery via clathrin dependent endocytosis. Clathrin mediated endo-
cytosis is typically inhibited using drugs such as chlorpromazine to pre-
vent formation of clathrin coated pits, or dynamin inhibitors to prevent
scission of the endosome from the membrane (Vercauteren et al.,
2010).
Several studies have identified clathrin mediated endocytosis as a
route for OMV entry. Vacuolating toxin VacA in H. pylori is an impor-
tant cytotoxic virulence factor that is found in OMVs during infection
(Parker, Chitcholtan, Hampton, & Keenan, 2010). VacA containing
OMVs entered host cells more efficiently than their VacA deficient
counterparts, in a cholesterol independent fashion, but inhibition of
clathrin mediated endocytosis by chlorpromazine had a stronger inhibi-
tion on VacA deficient OMVs, suggesting that VacA is not a receptor
ligand but may enable the OMVs to adapt to use alternative pathways
in the absence of the clathrin mediated pathway (Parker et al., 2010).
The OMVs were labeled with the lipophilic dye DiO, and intracellular
fluorescence was measured using flow cytometry (Table 1). It is not
clear whether membrane labeling of OMVs affects their function or
interaction with the membranes of host cells, and the affinity of lipo-
philic dyes for plasma membranes necessitates stringent controls and
washing steps to ensure the dye does not label the cell membrane in
addition to the vesicle (Mulcahy, Pink, & Carter, 2014). Lipophilic dye
molecules have been extensively used due to their efficient incorpora-
tion into membranes. However, the dye molecules can also form
aggregates and enriched domains resulting in changes to the mobility
and stiffness of the lipid bilayer, and these physical alterations may in
turn affect the behavior of the labeled membrane (Lulevich, Shih, Lo,
& Liu, 2009).
Contradictory findings to work from Parker et al. were presented
by Kaparakis et al. (2010), who observed that entry of H. pylori OMVs
was dependent on lipid rafts, and entry was significantly reduced after
sequestration of cholesterol from the host cell membrane. A similarfinding was also observed by Olofsson et al, which demonstrated a role
for lipid‐raft associated cholesterol in entry of H. pylori OMVs, which
was inhibited by treatment with methyl‐b cyclodextrin or filipin
(Olofsson et al., 2014). OMV release is a conserved phenomenon,
but there are considerable differences in composition and activity of
OMVs between species, between strains, and even between the same
strains under different external pressures (McBroom & Kuehn, 2007).
This may explain some of the discrepancies in the data regarding the
uptake routes of OMVs from the same species. The study by Kaparakis
et al used Alexa Fluor labeled OMVs, with antibody labeling used to
determine internalization and lipid raft stains to observe colocalization.
However, using light microscopy to observe OMVs can be problematic
due to their small size (often less than ~100 nm) and there is a need for
a more reliable and high resolution method of quantifying and identify-
ing internalization of OMVs, particularly when attempting to assess
colocalization of OMVs with particular compartments of the cell
(Mulcahy et al., 2014). Furthermore, antibody labeling may obscure
OMV epitopes important in determining association with host recep-
tors and thus, entry mechanism. Uptake of OMVs has been shown to
be a rapid process, with internalization detected as little as 15 min fol-
lowing infection (Wai et al., 2003). Many methods involving use of
immunofluorescence microscopy require fixation at pre‐determined
time points, and a live cell imaging method would be beneficial to
define the kinetics of OMV interactions with host cells.
Methods used to isolate OMVs can also vary, with most using
ultracentrifugation but others using sucrose gradients or commercially
available isolation columns (Chutkan, Macdonald, Manning, & Kuehn,
2013). The size of the OMV population is relevant when studying
endocytic routes; clathrin mediated endocytosis generally allows inter-
nalization of larger cargo than clathrin‐independent routes (El‐Sayed &
Harashima, 2013). Different isolation methods can introduce a bias
towards particular sizes of OMVs, for example with the use of filters
to exclude particles over 200 nm in diameter, and the lack of standard-
ized isolation procedures may also explain some of the differences in
findings in studies of OMVs from the same species(Kulp & Kuehn,
2010).
Other evidence for the entry of OMVs via receptor mediated
endocytosis was recently described by Vanaja et al. (2016) who
showed that in cells with an siRNA knockdown of AP2, an adaptor pro-
tein required for internalization of clathrin coated pits, there was a
reduced response to the LPS delivered by EHEC OMVs. This indicated
a reduction in the ability of the OMVs to enter the cell, which was also
observed when the LPS of the OMVs was neutralized with polymyxin
B, suggesting a functional link between LPS, clathrin and the induction
of inflammatory responses (Vanaja et al., 2016). The fate of the LPS
was to escape the endosomal compartments and induce caspase‐11
activity, causing cytokine production and cell death. LPS is a highly
immunogenic component of OMVs,(Vanaja et al., 2016) and modifica-
tion of LPS has been used as a way to reduce immunogenicity and
enhance the suitability of OMVs as an adjuvant in vaccine preparations
(Kim et al., 2009). The role of LPS during OMV host cell interactions is
thus an attractive and important area for further investigation.
Caspase induction was also observed after incubation with
enteroaggregative E. coli O104:H4 OMVs (Kunsmann et al., 2015).
Labeled OMVs were found to contain several antigens, including shiga
T
A
B
LE
1
O
ve
rv
ie
w
o
f
m
et
ho
ds
to
de
te
rm
in
e
O
M
V
up
ta
ke
by
ho
st
ce
lls
,t
he
ir
ad
va
nt
ag
es
an
d
di
sa
dv
an
ta
ge
s
M
et
ho
d
o
f
de
te
ct
in
g
O
M
V
up
ta
ke
by
ho
st
ce
lls
E
xt
er
na
l
B
o
un
d
In
te
rn
al
A
dv
an
ta
ge
s
o
f
m
et
ho
d
D
is
ad
va
nt
ag
es
R
ef
er
en
ce
s
A
nt
ib
o
dy
st
ai
ni
ng
✓
□
✓
□
✓
□
•
Sh
o
w
s
de
liv
er
y
o
f
O
M
V
ca
rg
o
•
A
llo
w
s
st
ud
y
o
f
co
nt
ri
bu
ti
o
ns
o
f
ca
rg
o
to
in
te
ra
ct
io
ns
w
it
h
ho
st
ce
ll
fo
r
bi
nd
in
g/
en
tr
y
pr
o
ce
ss
es
o
r
do
w
ns
tr
ea
m
ce
llu
la
r
ef
fe
ct
s
•
E
na
bl
es
vi
su
al
iz
at
io
n
o
f
co
lo
ca
liz
at
io
n
w
it
h
pa
rt
ic
ul
ar
ce
llu
la
r
co
m
pa
rt
m
en
ts
•
D
et
ec
ti
o
n
vi
a
fl
o
w
cy
to
m
et
ry
o
r
m
ic
ro
sc
o
py
•
M
ay
o
bs
cu
re
O
M
V
ep
it
o
pe
s
th
at
fa
ci
lit
at
e
up
ta
ke
•
R
eq
ui
re
s
pr
io
r
kn
o
w
le
dg
e
o
f
O
M
V
ca
rg
o
an
d
so
m
ay
ig
no
re
su
bp
o
pu
la
ti
o
ns
th
at
ar
e
no
t
de
te
ct
ed
w
it
h
th
e
an
ti
bo
dy
•
N
o
da
ta
o
n
ki
ne
ti
cs
o
f
up
ta
ke
du
e
to
re
qu
ir
em
en
t
o
f
fi
xa
ti
o
n
at
pr
e‐
de
te
rm
in
ed
ti
m
e
po
in
ts
•
N
ee
d
hi
gh
co
nc
en
tr
at
io
ns
o
f
O
M
V
s
an
d
ep
it
o
pe
s
in
o
rd
er
to
vi
su
al
iz
e
w
it
h
im
m
un
o
fl
uo
re
sc
en
ce
m
ic
ro
sc
o
py
F
u
ru
ta
et
al
.,
2
0
0
9
;
G
u
id
ie
t
al
.,
2
0
1
3
;
Ji
n
et
al
.,
2
0
1
1
;
K
ap
ar
ak
is
et
al
.,
2
0
1
0
;
K
im
et
al
.,
2
0
1
0
;
K
u
n
sm
an
n
et
al
.,
2
0
1
5
;
M
o
n
d
al
et
al
.,
2
0
1
6
;
P
ar
ke
r
et
al
.,
2
0
1
0
;
R
o
m
p
ik
u
n
ta
le
t
al
.,
2
0
1
2
;
T
h
ay
et
al
.,
2
0
1
4
;
V
an
aj
a
et
al
.,
2
0
1
6
Li
po
ph
ili
c
dy
es
fo
r
m
em
br
an
e
la
be
lin
g
eg
.D
iO
,P
K
H
2
6
✓
□
✓
□
✓
□
•
A
llo
w
s
la
be
lin
g
o
f
th
e
w
ho
le
O
M
V
po
pu
la
ti
o
n
•
C
an
de
te
rm
in
e
in
te
ra
ct
io
n
be
tw
ee
n
O
M
V
m
em
br
an
e
an
d
ho
st
re
ce
pt
o
rs
o
r
lip
id
ra
ft
re
gi
o
ns
•
C
an
be
us
ed
o
n
liv
e
ce
lls
to
re
so
lv
e
ki
ne
ti
cs
o
f
up
ta
ke
•
R
eq
ui
re
s
co
nt
ro
ls
to
pr
ev
en
t
la
be
lin
g
o
f
ho
st
ce
ll
m
em
br
an
e
w
it
h
ex
ce
ss
dy
e
•
W
as
hi
ng
st
ep
s
to
re
m
o
ve
ex
tr
ac
el
lu
la
r
ve
si
cl
es
•
M
em
br
an
e
la
be
lin
g
m
ay
af
fe
ct
no
rm
al
be
ha
vi
o
r
o
f
th
e
O
M
V
an
d
it
s
in
te
ra
ct
io
ns
w
it
h
th
e
ho
st
ce
ll
m
em
br
an
e
•
O
ft
en
re
qu
ir
ed
in
co
m
bi
na
ti
o
n
w
it
h
an
ti
bo
dy
la
be
lin
g
to
pr
o
ve
th
e
la
be
le
d
m
em
br
an
e
is
O
M
V
de
ri
ve
d
G
u
id
ie
t
al
.,
2
0
1
3
;
K
u
n
sm
an
n
et
al
.,
2
0
1
5
;
P
ar
ke
r
et
al
.,
2
0
1
0
;
T
h
ay
et
al
.,
2
0
1
4
;
W
al
le
r
et
al
.,
2
0
1
6
R
ho
da
m
in
e
R
1
8
✓
□
✓
□
•
A
llo
w
s
la
be
lin
g
o
f
th
e
w
ho
le
O
M
V
po
pu
la
ti
o
n
•
C
an
de
te
rm
in
e
in
te
ra
ct
io
n
be
tw
ee
n
O
M
V
m
em
br
an
e
an
d
ho
st
re
ce
pt
o
rs
o
r
lip
id
ra
ft
re
gi
o
ns
•
C
an
be
us
ed
o
n
liv
e
ce
lls
to
re
so
lv
e
ki
ne
ti
cs
o
f
up
ta
ke
•
R
eq
ui
re
s
co
nt
ro
ls
to
pr
ev
en
t
la
be
lin
g
o
f
ho
st
ce
ll
m
em
br
an
e
w
it
h
ex
ce
ss
dy
e
•
W
as
hi
ng
st
ep
s
to
re
m
o
ve
ex
tr
ac
el
lu
la
r
ve
si
cl
es
•
M
em
br
an
e
la
be
lin
g
m
ay
af
fe
ct
no
rm
al
be
ha
vi
o
r
o
f
th
e
O
M
V
an
d
it
s
in
te
ra
ct
io
ns
w
it
h
th
e
ho
st
ce
ll
m
em
br
an
e
•
O
ft
en
re
qu
ir
ed
in
co
m
bi
na
ti
o
n
w
it
h
an
ti
bo
dy
la
be
lin
g
to
pr
o
ve
th
e
la
be
le
d
m
em
br
an
e
is
O
M
V
de
ri
ve
d
B
o
m
b
er
ge
r
et
al
.,
2
0
0
9
;
R
o
m
p
ik
u
n
ta
le
t
al
.,
2
0
1
2
;
F
IT
C
la
be
lin
g
✓
□
✓
□
✓
□
•
A
llo
w
s
no
n
‐s
pe
ci
fi
c
la
be
lin
g
o
f
O
M
V
pr
o
te
in
s
•
C
an
be
us
ed
in
liv
e
ce
lls
to
re
so
lv
e
ki
ne
ti
cs
•
A
llo
w
s
de
te
ct
io
n
o
f
O
M
V
s
o
ut
si
de
an
d
in
si
de
ho
st
ce
lls
•
U
nk
no
w
n
ef
fe
ct
s
o
n
na
tu
ra
lO
M
V
be
ha
vi
o
rs
o
r
up
ta
ke
pr
o
ce
ss
es
•
N
o
n
‐s
pe
ci
fi
c
so
o
ft
en
re
qu
ir
ed
in
co
m
bi
na
ti
o
n
w
it
h
an
ti
bo
dy
la
be
le
d
co
m
po
ne
nt
s
C
h
at
te
rj
ee
&
C
h
au
d
h
u
ri
,
2
0
1
1
;K
es
ty
et
al
.,
2
0
0
4
;
P
o
lla
k
et
al
.,
2
0
1
2
;
Sc
h
aa
r
et
al
.,
2
0
1
1
;
Sh
ar
p
e
et
al
.,
2
0
1
1
O
M
V
ta
rg
et
ed
G
F
P
✓
□
✓
□
✓
□
•
N
o
pr
o
ce
ss
in
g
re
qu
ir
ed
•
C
an
be
us
ed
in
liv
e
ce
lls
•
St
ro
ng
ly
fl
uo
re
sc
en
t
an
d
sp
ec
if
ic
to
O
M
V
s
•
N
o
o
bs
er
va
bl
e
ef
fe
ct
s
o
n
O
M
V
s
o
r
ho
st
ce
lls
•
A
da
pt
ab
le
pl
at
fo
rm
fo
r
st
ud
y
o
f
O
M
V
s
•
T
ar
ge
ti
ng
se
qu
en
ce
sp
ec
if
ic
fo
r
E.
co
li,
no
t
te
st
ed
fo
r
o
th
er
sp
ec
ie
s
•
N
ee
d
to
en
gi
ne
er
an
d
ve
ri
fy
st
ra
in
pr
io
r
to
us
e
K
im
et
al
.,
2
0
0
8
.
O
M
V
la
be
le
d
w
it
h
cl
ea
va
bl
e
di
su
lp
hi
de
lin
ke
r
✓
□
✓
□
✓
□
•
D
is
ti
ng
ui
sh
es
bo
un
d
fr
o
m
in
te
rn
al
is
ed
O
M
V
s
•
Se
ns
it
iv
e
sy
st
em
w
it
h
lo
w
ba
ck
gr
o
un
d
•
D
o
es
n'
t
re
qu
ir
e
pr
io
r
kn
o
w
le
dg
e
o
f
O
M
V
ca
rg
o
o
r
ep
it
o
pe
s
•
C
an
qu
an
ti
fy
O
M
V
up
ta
ke
an
d
is
ad
ap
ta
bl
e
fo
r
hi
gh
th
ro
ug
hp
ut
ap
pl
ic
at
io
ns
•
R
eq
ui
re
s
w
as
h
st
ep
s
an
d
co
nt
ro
ls
to
en
su
re
re
du
ct
io
n
o
f
lin
ke
r
•
C
el
ls
re
qu
ir
e
fi
xa
ti
o
n
at
pr
e‐
de
te
rm
in
ed
ti
m
e
po
in
ts
•
M
em
br
an
e
la
be
lin
g
o
f
O
M
V
s
ha
s
un
kn
o
w
n
ef
fe
ct
s
o
n
th
ei
r
be
ha
vi
o
r.
O
lo
fs
so
n
et
al
.,
2
0
1
4
O'DONOGHUE AND KRACHLER 1511
1512 O'DONOGHUE AND KRACHLERtoxin, flagellin and enterotoxin, and caused cell death by the induction
of caspase‐9 mediated apoptosis, and inflammation through increased
IL‐8 release (Kunsmann et al., 2015). Treatment with dynasore and
chlorpromazine significantly reduced the uptake of OMVs, suggesting
entry of OMVs and their cargo occurs via the receptor mediated
endocytic pathway (Kunsmann et al., 2015). Neutralization of OMV
LPS with polymyxin B reduced the secretion of IL‐8, in agreement with
other studies indicating a role of LPS in driving pro‐inflammatory
responses (Kunsmann et al., 2015; Vanaja et al., 2016).
OMVs from EHEC containing the hemolysin HlyA were shown to
enter host cells, with HlyA released from lysosomes into the cytoplasm
where it was then trafficked to mitochondria, resulting in caspase‐3
and caspase‐9 activation and subsequent death of epithelial and endo-
thelial cells (Bielaszewska et al., 2013). Treatment with dynasore and
chlorpromazine significantly reduced OMV entry, suggesting EHEC‐
HlyA OMVs enter via clathrin mediated endocytosis. Fluorescence
microscopy confirmed the colocalization of HlyA and clathrin, while
there was no colocalization observed between HlyA and caveolin
(Bielaszewska et al., 2013). When free HlyA was added to the cells, it
remained at the cell surface and was not internalized, suggesting that
the association with OMVs is necessary to allow efficient delivery into
the cell (Bielaszewska et al., 2013).
Many studies have demonstrated a role for clathrin in the internal-
ization of OMVs, but with the caveat that OMVs are able to compen-
sate well in the absence of this entry route. Similarly to the finding by
Parker et al that OMVs can utilize more than one route of entry, OMVs
from A. actinomycetemcomitans showed a 25% reduction in uptake
when clathrin mediated endocytosis was inhibited by monensin, and
an equivalent reduction when cholesterol was bound by filipin (Parker
et al., 2010; Thay et al., 2014). OMVs from Brucella abortus were also
shown to enter monocytes primarily via a clathrin dependent route,
with monodansylcadaverine treatment resulting in a 33% inhibition
of OMV entry, and no effect seen after filipin treatment (Pollak,
Delpino, Fossati, & Baldi, 2012). However, the partial level of inhibition
implies that the OMVs are able to use alternative pathways. Interest-
ingly, the study also showed that pre‐incubation with OMVs prior to
infection with whole cells inhibited the TNF‐h responses, and increased
the numbers of internalized B. abortus, demonstrating a role for OMVs
in immunomodulation during or prior to subsequent infection. The
ability of toll‐like receptors to activate upon addition of their agonists
was also reduced after pre‐treatment with OMVs (Pollak et al.,
2012). This study was conducted with monocytes rather than epithelial
cells and there may be differences in entry of OMVs into phagocytic
cells compared with non‐phagocytic cell lines used in many studies
(Pollak et al., 2012).
Incomplete levels of inhibition were also seen in studies with
H. pylori OMVs, with a method termed ‘Quantification of internalised
substances’ which labeled the H. pylori OMVs with a dye containing a
cleavable disulphide bond, allowing quenching of extracellular OMV‐
associated fluorescence by the addition of a reducing agent (Olofsson
et al., 2014; Table 1). Fluorescence inside the epithelial cells was then
assessed with microscopy (Olofsson et al., 2014). This work demon-
strated involvement of dynamin, with dynamin inhibition causing an
80% reduction in internalization, but chlorpromazine only reducing
internalization by 40% (Olofsson et al., 2014). Dynamin is involved inboth clathrin mediated and caveolin mediated endocytosis, and so it
appears that there is a contribution of both clathrin mediated and
caveolin mediated endocytosis towards OMV entry (Vercauteren
et al., 2010).
Entry into a cell via the clathrin mediated endocytic pathway typ-
ically utilizes receptor‐ligand binding to drive internalization (El‐Sayed
& Harashima, 2013). While this route has been implicated in many
studies of OMV entry, the possible ligands have remained elusive. If
internalization of OMVs requires these interactions, then identifying
the components involved could allow the design of inhibitors to atten-
uate infections by preventing the delivery of OMV‐associated viru-
lence factors.4 | NON CLATHRIN MEDIATED
ENDOCYTOSIS
Many studies have indicated a role for lipid rafts in enabling OMV
entry(Furuta et al., 2009; Kaparakis et al., 2010; Jin et al., 2011; Schaar
et al., 2011; Sharpe, Kuehn, & Mason, 2011; Elmi et al., 2012; Kim
et al., 2010; Thay et al., 2014; Mondal et al., 2016) . Lipid rafts are
domains of the plasma membrane that are enriched in sphingolipids
and cholesterol (Mulcahy et al., 2014). The lipid composition of these
domains causes them to be more ordered and compact than neighbor-
ing regions (Simons & Ehehalt, 2002). Cholesterol‐rich regions are
abundant in the bilayer, and it is hypothesized that clustering of the
regions allows curvature of the membrane, driving formation of invag-
inations in the host cell and entry of particles into the cell (Pelkmans,
2005). It is well‐established that viruses exploit lipid rafts to enter host
cells and the similarities between enveloped viruses and OMVs in
terms of size and composition would suggest a potential affinity for
this route of entry (Kulp & Kuehn, 2010).
Cholesterol is a principal component of lipid raft domains, and
cholesterol dependency has been demonstrated for entry of OMVs
from a variety of species (Bomberger et al., 2009; Furuta et al., 2009;
Kim et al., 2010; Jin et al., 2011; Schaar et al., 2011; Sharpe et al.,
2011; Elmi et al., 2012; Olofsson et al., 2014; Thay et al., 2014; Mondal
et al., 2016). Cholesterol‐rich microdomains are commonly disrupted
by using chemicals such as methyl‐β‐cyclodextrin (mbcd, sequesters
and depletes cholesterol from the cell membrane) or filipin (binds to
cholesterol in the membrane and disrupts lipid packing, Danthi &
Chow, 2004; Vercauteren et al., 2010). Many reports have used this
approach to demonstrate the importance of membrane cholesterol
for delivery of OMV cargo. OMVs from Vibrio vulnificus delivered cyto-
lysins into epithelial cells to induce cell death, but this effect was
diminished in the presence of filipin (Kim et al., 2010). Treatment with
mbcd prevented delivery of OmpA from A. baumannii OMVs to host
cells (Jin et al., 2011). OMVs commonly cause immune activation via
the induction of cytokines, and their production is measured using
ELISAs to determine the level of inflammatory stimulation (Schaar
et al., 2011; Sharpe et al., 2011; Elmi et al., 2012; Pollak et al., 2012;
Kunsmann et al., 2015; Mondal et al., 2016; Waller et al., 2016). Treat-
ment of host cells with mbcd prior to infection with OMVs from Cam-
pylobacter jejuni resulted in reduced production of IL‐8, IL‐6 and TNF‐α
(Elmi et al., 2012). The cargo of OMVs can also assist in allowing lipid‐
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P. aeruginosa displayed PaAP aminopeptidase on the surface and
showed a 40% higher association with lung cells than the OMVs from
a PaAP deletion strain, and this association was dependent on mem-
brane cholesterol (Bauman & Kuehn, 2009).4.1 | Caveolin mediated endocytosis
Lipid raft domains can also be enriched in caveolin, and the oligomeri-
zation of caveolin allows formation of caveolae (Rewatkar et al., 2015).
Caveolae are cave‐shaped invaginations that are formed on the cell
membrane, around 80 nm in diameter, and enriched in cholesterol,
caveolins, and sphingolipids (Mulcahy et al., 2014). Similarly to clathrin
mediated endocytosis, dynamin is also required for scission and inter-
nalization of caveolae (Rewatkar et al., 2015). Although the speed of
caveolae internalization is around five times slower than that of
clathrin mediated endocytosis, the efficiency of cargo delivery into
the cytosol is much higher (Ritter et al., 1995).
Interactions between pathogens and caveolae have been
reported, has and caveolae have been suggested as a preferential inva-
sion mechanism for many pathogens, including bacteria, viruses and
fungi, as the internalised caveolae are thought to avoid fusion with
lysosomal compartments and subsequent degradation, in contrast to
clathrin coated pits (Anderson, Chen, & Norkin, 1996; Long et al.,
2012; Lim et al., 2014). E. coli and Leishmania chagasi internalized via
caveolae are able to persist within macrophages (Baorto et al., 1997;
Rodriguez, Gaur, & Wilson, 2006). Chlamydial species are able to avoid
detection during intracellular infection by using caveolins to disguise
the internalized phagosome as a host‐derived vesicle (Norkin,
Wolfrom, & Stuart, 2001). Simian virus 40 (SV40) also enters host cells
through caveolae, and uptake of exosomes produced from cells
infected with Epstein Barr virus also requires caveolae (Anderson
et al., 1996; Nanbo, Kawanishi, Yoshida, & Yoshiyama, 2013).
There are now numerous examples of OMVs utilizing caveolin
mediated endocytosis to enter host cells. However, many studies often
fail to distinguish between lipid raft dependency, which is inhibited by
cholesterol depletion, and caveolin‐specific lipid raft dependency,
which is sensitive to both cholesterol and dynamin depletion. OMVs
from non‐typeable Haemophilus influenzae were shown to enter and
colocalize with caveolin 1 (Cav‐1), a marker of caveolae, by western
blotting of epithelial cell lysates after infection (Sharpe et al., 2011).
Treatment of cells with filipin to disrupt cholesterol rich microdomains
in the membrane abolished this interaction. The same study showed
that while binding of OMVs to the cell membrane could occur at 4°
C, internalization only occurred after incubation at 37°C. This is in
agreement with work by Kesty et al. (2004) which showed reduced
entry of ETEC OMVs into HT29 intestinal epithelial cells at 4°C com-
pared with 37°C, and also by Jager et al. (2014) which demonstrated
the temperature dependence of uptake for OMVs from Legionella
pneumophila, suggesting that OMV entry is not a passive process.
Caveolin mediated endocytosis of OMVs has been found in many
cases to utilize interactions between bacterial ligands and host cell
receptors. OMVs from Moraxella catarrhalis entered human epithelial
cells via interactions between toll‐like receptor 2 (TLR2) and lipid rafts
(Schaar et al., 2011). Internalization of FITC‐labeled OMVs was notobserved after treatment with filipin, suggesting that the receptors
were localized in cholesterol‐rich regions of the membrane. Cholera
toxin (CTx) is a virulence factor of Vibrio cholerae known to bind to
the ganglioside GM1 present in caveolin enriched lipid rafts on the
host cell surface, and is secreted in both soluble and OMV‐associated
forms (Chatterjee & Chaudhuri, 2011). During infection of intestinal
epithelial cells, OMV‐associated CTx was shown to rapidly target
GM1 after only 15 min and facilitate internalization of the OMVs
(Chatterjee & Chaudhuri, 2011). Similarly, entry of ETEC OMVs relied
on the association of heat LT contained within the OMV membrane
with the toxin receptor, and immunofluorescence microscopy revealed
colocalization of labeled caveolin and vesicles (Kesty et al., 2004).
OMVs derived from an LT deficient strain showed a 60% lower associ-
ation with host cells, demonstrating the role of specific OMV cargo in
driving uptake processes. Together, these reports suggest that OMVs
from pathogens are adapted for delivery of virulence factors (Kesty
et al., 2004).4.2 | Non caveolin mediated endocytosis
Alternatively, lipid raft mediated endocytosis can be independent of
caveolin and dynamin and instead require small GTPases (Rewatkar
et al., 2015). These GTPase dependent processes are the least well
characterized of endocytic routes, but are generally defined as uptake
into the cell via uncoated membrane invaginations (Mayor, Parton, &
Donaldson, 2014).
OMV‐associated proteases from V. cholerae reportedly were deliv-
ered into intestinal epithelial cells via this dynamin independent, lipid
raft mediated endocytic route (Mondal et al., 2016). Induction of pro‐
inflammatory cytokines following infection with OMVs was measured
using ELISA, and cytotoxicity determined using flow cytometry. Both
responses were reduced after treatment with mbcd to deplete choles-
terol, but no effect was observed after dynamin inhibition (Mondal
et al., 2016). The oral pathogen Porphyromonas gingivalis secretes
OMVs containing virulence factors such as gingipains and fimbriae,
and these OMVs were shown to enter HeLa and gingival epithelial cells
in a Rac1/lipid raft dependent manner, and independent of caveolin,
clathrin, and dynamin (Furuta et al., 2009). Interestingly, these OMVs
were rapidly directed to lysosomes, but avoided degradation for over
24 hr following entry (Furuta et al., 2009). Despite being unable to
deliver their contents into the cytosol, the strong and prolonged acid-
ification of lysosomes induced by the OMVs caused cellular damage,
even without delivery of specific virulence factors (Furuta et al., 2009).
OMVs can also influence host cellular responses without entering
cells. When all endocytic routes were inhibited, OMVs from P. gingivalis
were still able to cause suppression of immune signaling and increase
tolerance to subsequent infection through the induction of TLR4 on
the cell surface of monocytes (Waller et al., 2016). In some cases,
OMVs can even cause effects in host cells distal from the initial site
of infection and OMV production. OMVs from Salmonella enterica
were produced by whole bacteria in the Salmonella containing vacuole
(SCV) and the vesicles were able to escape not just the SCV but the
infected host cell, and enter uninfected neighboring cells to deliver
the genotoxin cytolethal distending toxin (CDT), revealing the ability
of OMVs to migrate from the cell of origin (Guidi et al., 2013).
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Despite the different architecture of the membrane bilayer present in
OMVs and that of host eukaryotic cells, membrane fusion has been
described as a mechanism for OMV entry into host cells. The self‐
quenching fluorescent dye Rhodamine‐R18 was used to label OMVs
from P. aeruginosa (Bomberger et al., 2009). When added to host epi-
thelial cells, an increase in fluorescence was observed due to lipid
mixing between vesicle and host membrane bilayer, leading to dilution
and de‐quenching of the dye. The increase in fluorescence was used as
a quantitative determinant of membrane fusion between the OMV and
the cell membrane (Bomberger et al., 2009). Lipid rafts were labeled
with CTxB subunit, and there was colocalization between sites of
membrane fusion and the labeled lipid rafts, and the fusion events
were inhibited in the presence of filipin. This indicated that membrane
fusion events preferentially occur at lipid raft domains (Bomberger
et al., 2009). A similar technique was used to assess membrane fusion
between OMVs from A. actinomycetemcomitans and HeLa cells, which
utilized confocal microscopy to identify colocalization between the
toxin component cytolethal distending toxin (CDT) and the labeled
lipid rafts and sites of dequenched membrane labeling (Rompikuntal
et al., 2012). A caveat of studies employing mbcd and filipin to deduce
the involvement of lipid rafts in OMV uptake is that both agents, by
disrupting a major constituent of the membrane, affect membrane
organization on a large scale and may have effects on processes not
limited to lipid rafts.
Model membranes have been utilized to confirm that membrane
fusion can occur between OMVs and host cell membranes, despite
their structural differences. Phospholipid liposomes mimicking host cell
membranes were labeled with a pair of FRET dyes to demonstrate that
OMV membrane material from L. monocytogenes can be included into
the model host bilayer, by monitoring the change in FRET signal, which
increased upon incorporation of OMV membrane due to an increase in
surface area (Jager et al., 2014). The fusion events occurred just sec-
onds after addition of OMVs, highlighting the rapid and efficient kinet-
ics behind OMV interactions with host cells (Jager et al., 2014). The
interaction was also observed to be partially temperature dependent,
with a lower level of incorporation when the experiment was
conducted at 4°C compared to 37°C, but there was still a notable level
of membrane fusion detected, suggesting that fusion does not entirely
depend on active, energetic processes (Jager et al., 2014).6 | CONCLUSIONS
There are considerable discrepancies between findings determining
OMV entry routes into host cells. Differences in uptake routes
between OMVs from different species may well be explained by the
fact that OMV composition is adapted to direct vesicles towards a spe-
cific uptake route, and thus allow them to undergo ideal processing
within the host cell to facilitate infection. However, discrepancies also
exist between studies analyzing entry of OMVs from the same species.
This may be due to discrepancies in methodologies, such as the isola-
tion and quantification of OMVs, the labeling or imaging techniques,
or the strains, host cell types and cell lines used. It is also apparent thatOMVs can use multiple routes to enter host cells. As described above,
different isolation techniques result in different levels of purity and/or
size distributions of theOMVpreparations. Quantification ofOMVs used
for uptake assays also varies between studies, and particularly the use of
total protein contained within the OMV preparation as a means of nor-
malization is problematic, as protein content and composition can vary
widely between OMV preparations derived under different growth con-
ditions (McBroom&Kuehn, 2007). Despite these challenges, the existing
literature clearly demonstrates that OMVs are well adapted to direct and
deliver their cargo into host cells. In order to fully elucidate the mecha-
nisms underpinning these processes, it will be necessary to develop a
consistent, quantifiable and dynamic approach to measure OMV associ-
ation, entry and cargo delivery to host cells.
Deepening our understanding of how specific cargo molecules
direct OMVs towards a specific uptake route, and thus, determine
the fate of vesicular contents within the host cell is essential and will
allow the future exploitation of OMVs for medical applications
(Berleman & Auer, 2013). OMVs engineered to display a ClyA‐HER2
targeting probe were able to target cells over‐expressing HER2, a com-
mon biomarker of cancer cells, and induce cell death and tumor shrink-
age via the delivery of siRNA targeting the expression of kinesin
spindle protein (Gujrati et al., 2014). Insights on OMV adhesion and
entry would allow production of engineered OMVs with high affinity
for specific cell types or tissue locations, and enhance their potential
as novel therapeutic agents (Alves, Turner, Medintz, & Walper, 2015;
Gao et al., 2015).
OMVs have already been incorporated in vaccine preparations,
due to their immunogenicity and the display of antigens, which unlike
purified antigen or heat‐killed bacteria, closely reflects the native con-
formation in the bacterial cells of origin. However, fewer risks are asso-
ciated with the use of OMVs compared to live‐cell vaccine
preparations, as OMVs are metabolically inert (Collins, 2011; Acevedo
et al., 2014; Brudal et al., 2015). Novel targets against bacterial infec-
tion are urgently required due to the increasing prevalence of antibi-
otic resistance (Kulkarni, Nagaraj, & Jagannadham, 2015). The
importance of OMVs in infection is now well demonstrated, with the
delivery of active virulence factors and immunomodulatory molecules,
as well as their defensive roles, all serving to enhance pathogenesis
(MacDonald & Kuehn, 2012). Insights into the mechanisms of OMV
entry may enable the design of inhibitors to prevent the delivery of
their toxic cargo and attenuate infections without selecting for antibi-
otic resistance (Kulkarni et al., 2015).
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